Ofra Golani

Weizmann Institute of Science — Israel

Medicine · Health Sciences

27h-index5.5kcitations162works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(37), Single-cell and spatial transcriptomics(33), Cancer Genomics and Diagnostics(28), Immunotherapy and Immune Responses(25), Cancer, Stress, Anesthesia, and Immune Response(21)

Publications162 total

WIS-MICC-CellObservatory/Ewing-Sarcoma-Proteomics-and-Immune-Landscape: Release for publication
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
WIS-MICC-CellObservatory/Ewing-Sarcoma-Proteomics-and-Immune-Landscape: Release for publication
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
Integrated spatial proteomic analysis of breast cancer heterogeneity unravels cancer cell phenotypic plasticity
Nature Communications·2025Open Access
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures
Nature Cancer·2025
Defining Functions of Maternal Macrophage subpopulations During Placental Development
Placenta·2025
Uncovering a New Adaptive Mechanism: The Impact of Gestational Hypoxia on Placental-Fetal Oxygen Transfer
Placenta·2025
Subcellular mRNA localization patterns across tissues resolved with spatial transcriptomics
2025Open Access
Prenatal stress induces transient developmental alterations in distinct GABAergic populations and leads to long-lasting behavioral abnormalities
Neurobiology of Stress·2025Open Access
Supplementary Figure 5 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 5 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Table 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 4 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 4 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Figure 6 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Supplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025Open Access
Data from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
2025· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Shifra Ben‐Dor(8), Yoseph Addadi(8), Michal Neeman(7), Ravid Straussman(4), Raya Eilam(4), Hadas Keren‐Shaul(4), Merav Kedmi(4), Benjamin Geiger(4), Perrine Paul‐Gilloteaux(4), Giuseppe Mallel(3), Maya Dadiani(3), Jennifer A. Wargo(3), Ron Rotkopf(3), Ronen Levy(3), Michal Lotem(3), Yishai Levin(3), Eytan Ruppin(3), Yardena Samuels(3), Karina Yaniv(3), Shalev Itzkovitz(3)